Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Belén Rivero Gutierrez"'
Autor:
Darci Phillips, Magdalena Matusiak, Belén Rivero Gutierrez, Salil S. Bhate, Graham L. Barlow, Sizun Jiang, Janos Demeter, Kimberly S. Smythe, Robert H. Pierce, Steven P. Fling, Nirasha Ramchurren, Martin A. Cheever, Yury Goltsev, Robert B. West, Michael S. Khodadoust, Youn H. Kim, Christian M. Schürch, Garry P. Nolan
Publikováno v:
Nature Communications, Vol 12, Iss 1, Pp 1-18 (2021)
PD-1 blockade is effective for only a subset of patients with cutaneous T cell lymphomas. Here, the authors report a spatial biomarker that uses immune and cancer cell topography to predict response to PD-1 blockade in this disease.
Externí odkaz:
https://doaj.org/article/185b95b3ae0241efb2f75ef0ed8fba8c
Autor:
Carolina Zambrano, Agné Kulyté, Juán Luján, Belén Rivero-Gutierrez, Fermín Sánchez de Medina, Olga Martínez-Augustin, Mikael Ryden, Frank A. J. L. Scheer, Marta Garaulet
Publikováno v:
Frontiers in Endocrinology, Vol 14 (2023)
Background and purposeNapping is a widespread practice worldwide and has in recent years been linked to increased abdominal adiposity. Lipase E or LIPE encodes the protein hormone-sensitive lipase (HSL), an enzyme that plays an important role in lipi
Externí odkaz:
https://doaj.org/article/4dcd21a666294432879f5f9dd692f48f
Autor:
Kimberly S. Smythe, Darci J. Phillips, Robert H. Pierce, Salil S. Bhate, Yury Goltsev, Youn H. Kim, Magdalena Matusiak, Christian M. Schürch, Steven P. Fling, Garry P. Nolan, Martin A. Cheever, Janos Demeter, Graham L. Barlow, Sizun Jiang, Nirasha Ramchurren, Robert West, Michael S. Khodadoust, Belén Rivero Gutierrez
Publikováno v:
Nature Communications
Nature Communications, Vol 12, Iss 1, Pp 1-18 (2021)
Nature Communications, Vol 12, Iss 1, Pp 1-18 (2021)
Cutaneous T cell lymphomas (CTCL) are rare but aggressive cancers without effective treatments. While a subset of patients derive benefit from PD-1 blockade, there is a critically unmet need for predictive biomarkers of response. Herein, we perform C
Autor:
Darci J. Phillips, Steven P. Fling, Robert H. Pierce, Robert B. West, Belén Rivero Gutierrez, Christian M. Schürch, Magdalena Matusiak, Graham L. Barlow, Martin A. Cheever, Youn H. Kim, Salil S. Bhate, Michael S. Khodadoust, Nirasha Ramchurren, Garry P. Nolan
Publikováno v:
Cancer Research. 80:6669-6669
Cutaneous T-cell lymphoma (CTCL) is a rare, incurable CD4+ T cell malignancy of the skin with a 5-year survival rate of less than 30% in advanced stages. Immune checkpoint inhibitors, such as anti-PD-1 antibodies, have shown dramatic clinical efficac